Cohen, A. ., Wallenhorst, C. ., Rivera, M. ., Ay, C. ., Schaefer, B. ., Abdelgawwad, K. ., … Martinez, C. . (2024). Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study. Thromb Haemost. http://doi.org/10.1055/a-2259-0662
C. Wallenhorst
First name
C.
Last name
Wallenhorst
Cohen, A. T., Wallenhorst, C. ., Choudhuri, S. ., Nassar, A. ., Pollock, K. G., & Martinez, C. . (2023). A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer. Thromb Haemost. http://doi.org/10.1055/a-2145-7238
Martinez, C. ., Wallenhorst, C. ., McFerran, D. ., & Hall, D. A. (2015). Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England. Ear Hear. http://doi.org/10.1097/aud.0000000000000121
Martinez, C. ., Katholing, A. ., Wallenhorst, C. ., Granziera, S. ., Cohen, A. T., & Freedman, S. B. (2015). Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. Heart. http://doi.org/10.1136/heartjnl-2015-307808
Martinez, C. ., Katholing, A. ., Wallenhorst, C. ., & Freedman, S. B. (2016). Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study. Thromb Haemost. http://doi.org/10.1160/th15-04-0350
Cairns, V. ., Wallenhorst, C. ., Rietbrock, S. ., & Martinez, C. . (2019). Incidence of Lyme disease in the UK: a population-based cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2018-025916
Field, T. S., Weijs, B. ., Curcio, A. ., Giustozzi, M. ., Sudikas, S. ., Katholing, A. ., … Martinez, C. . (2019). Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. http://doi.org/10.1055/s-0039-1683429
Giustozzi, M. ., Curcio, A. ., Weijs, B. ., Field, T. S., Sudikas, S. ., Katholing, A. ., … Cohen, A. T. (2020). Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. http://doi.org/10.1055/s-0040-1709527
Martinez, C. ., Wallenhorst, C. ., Rietbrock, S. ., & Freedman, B. . (2020). Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.014376
Martinez, C. ., Katholing, A. ., Wallenhorst, C. ., & Cohen, A. T. (2020). Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients. Br J Haematol. http://doi.org/10.1111/bjh.16383